- Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
-
Ayoub F, Odenwald M, Micic D, Dalal SR, Pekow J, Cohen RD, Rubin DT, Sakuraba A
- KMID: 2529570
- Intest Res.
- 2022 Apr;20(2):240-250.
- doi: 10.5217/ir.2021.00091
Background/Aims: Perianal fistulas are a debilitating manifestation of Crohn’s disease (CD). Despite the advent of anti-tumor necrosis factor (anti-TNF) therapy, the medical management of fistulizing CD continues to be challenged... -
- CITED
-
- Close
- SHARE
-
- Close
